
Now published the non-clinical package for the #ILP100 #oral being developed as first-line-treatment for ICI-induced colitis.
Read how the the bacteria interacts with the immune system at Peyers Patches and delivers the #CXCL12 here: journals.physiology.org/doi/epdf/10.11…
English















